Literature DB >> 16227992

Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo.

Juhua Chen1, Payaningal R Somanath, Olga Razorenova, William S Chen, Nissim Hay, Paul Bornstein, Tatiana V Byzova.   

Abstract

Akt kinases control essential cellular functions, including proliferation, apoptosis, metabolism and transcription, and have been proposed as promising targets for treatment of angiogenesis-dependent pathologies, such as cancer and ischemic injury. But their precise roles in neovascularization remain elusive. Here we show that Akt1 is the predominant isoform in vascular cells and describe the unexpected consequences of Akt1 knockout on vascular integrity and pathological angiogenesis. Angiogenic responses in three distinct in vivo models were enhanced in Akt1(-/-) mice; these enhanced responses were associated with impairment of blood vessel maturation and increased vascular permeability. Although impaired vascular maturation in Akt1(-/-) mice may be attributed to reduced activation of endothelial nitric oxide synthase (eNOS), the major phenotypic changes in vascular permeability and angiogenesis were linked to reduced expression of two endogenous vascular regulators, thrombospondins 1 (TSP-1) and 2 (TSP-2). Re-expression of TSP-1 and TSP-2 in mice transplanted with wild-type bone marrow corrected the angiogenic abnormalities in Akt1(-/-) mice. These findings establish a crucial role of an Akt-thrombospondin axis in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227992      PMCID: PMC2277080          DOI: 10.1038/nm1307

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  45 in total

1.  p21-activated kinase regulates endothelial permeability through modulation of contractility.

Authors:  Rebecca A Stockton; Erik Schaefer; Martin Alexander Schwartz
Journal:  J Biol Chem       Date:  2004-08-27       Impact factor: 5.157

2.  Microvascular patterning is controlled by fine-tuning the Akt signal.

Authors:  Jing Fang Sun; Thuy Phung; Ichiro Shiojima; Terri Felske; J Nalinee Upalakalin; Dian Feng; Tad Kornaga; Talia Dor; Ann M Dvorak; Kenneth Walsh; Laura E Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

3.  Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve.

Authors:  Jun Yu; Ebo D deMuinck; Zhenwu Zhuang; Mary Drinane; Katalin Kauser; Gabor M Rubanyi; Hu Sheng Qian; Takahisa Murata; Bruno Escalante; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

4.  PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury.

Authors:  Tomohisa Nagoshi; Takashi Matsui; Takuma Aoyama; Annarosa Leri; Piero Anversa; Ling Li; Wataru Ogawa; Federica del Monte; Judith K Gwathmey; Luanda Grazette; Brian A Hemmings; Brian Hemmings; David A Kass; Hunter C Champion; Anthony Rosenzweig
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

5.  Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium.

Authors:  Natalya V Narizhneva; Olga V Razorenova; Eugene A Podrez; Juhua Chen; Unni M Chandrasekharan; Paul E DiCorleto; Edward F Plow; Eric J Topol; Tatiana V Byzova
Journal:  FASEB J       Date:  2005-04-15       Impact factor: 5.191

6.  VEGF-integrin interplay controls tumor growth and vascularization.

Authors:  Sarmishtha De; Olga Razorenova; Noel Patrick McCabe; Timothy O'Toole; Jun Qin; Tatiana V Byzova
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

7.  The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells.

Authors:  Mahdhia Soula-Rothhut; Cyrille Coissard; Hervé Sartelet; Cédric Boudot; Georges Bellon; Laurent Martiny; Bernard Rothhut
Journal:  Exp Cell Res       Date:  2004-11-23       Impact factor: 3.905

8.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Authors:  Ichiro Shiojima; Kaori Sato; Yasuhiro Izumiya; Stephan Schiekofer; Masahiro Ito; Ronglih Liao; Wilson S Colucci; Kenneth Walsh
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

9.  Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis.

Authors:  Eric Ackah; Jun Yu; Stefan Zoellner; Yasuko Iwakiri; Carsten Skurk; Rei Shibata; Noriyuki Ouchi; Rachael M Easton; Gennaro Galasso; Morris J Birnbaum; Kenneth Walsh; William C Sessa
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

10.  Akt1 in the cardiovascular system: friend or foe?

Authors:  Brian T O'Neill; E Dale Abel
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more
  197 in total

1.  Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands.

Authors:  Xiaoxia Z West; Nikolay L Malinin; Alona A Merkulova; Mira Tischenko; Bethany A Kerr; Ernest C Borden; Eugene A Podrez; Robert G Salomon; Tatiana V Byzova
Journal:  Nature       Date:  2010-10-03       Impact factor: 49.962

2.  Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis.

Authors:  Noemi Rotllan; Aránzazu Chamorro-Jorganes; Elisa Araldi; Amarylis C Wanschel; Binod Aryal; Juan F Aranda; Leigh Goedeke; Alessandro G Salerno; Cristina M Ramírez; William C Sessa; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  FASEB J       Date:  2014-11-12       Impact factor: 5.191

3.  De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation.

Authors:  Xiaochao Wei; Jochen G Schneider; Sherene M Shenouda; Ada Lee; Dwight A Towler; Manu V Chakravarthy; Joseph A Vita; Clay F Semenkovich
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

4.  Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development.

Authors:  Fei Zhou; Zai Chang; Luqing Zhang; Young-Kwon Hong; Bin Shen; Bo Wang; Fan Zhang; Guangming Lu; Denis Tvorogov; Kari Alitalo; Brian A Hemmings; Zhongzhou Yang; Yulong He
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

5.  Novel bioactivity of NHERF1 in corneal neovascularization.

Authors:  Peng Chen; Ye Wang; Lingling Yang; Changyou Li; Yao Wang; Lixin Xie; Yiqiang Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-10       Impact factor: 3.117

Review 6.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

7.  c-Cbl inhibition improves cardiac function and survival in response to myocardial ischemia.

Authors:  Khadija Rafiq; Mikhail A Kolpakov; Rachid Seqqat; Jianfen Guo; Xinji Guo; Zhao Qi; Daohai Yu; Bhopal Mohapatra; Neha Zutshi; Wei An; Hamid Band; Archana Sanjay; Steven R Houser; Abdelkarim Sabri
Journal:  Circulation       Date:  2014-02-28       Impact factor: 29.690

8.  Amniotic fluid stem cells prevent β-cell injury.

Authors:  Valentina Villani; Anna Milanesi; Sargis Sedrakyan; Stefano Da Sacco; Susanne Angelow; Maria Teresa Conconi; Rosa Di Liddo; Roger De Filippo; Laura Perin
Journal:  Cytotherapy       Date:  2013-11-07       Impact factor: 5.414

Review 9.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 10.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.